X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (271) 271
male (169) 169
female (156) 156
hematology (151) 151
middle aged (143) 143
index medicus (141) 141
oncology (122) 122
adult (118) 118
aged (97) 97
medicine & public health (55) 55
treatment outcome (52) 52
transplantation (45) 45
lymphomas (44) 44
aged, 80 and over (43) 43
cancer (43) 43
chemotherapy (36) 36
adolescent (35) 35
antineoplastic combined chemotherapy protocols - therapeutic use (35) 35
prognosis (34) 34
antineoplastic agents - therapeutic use (30) 30
recurrence (29) 29
hematopoietic stem cell transplantation (28) 28
therapy (28) 28
leukemia (27) 27
young adult (27) 27
antineoplastic agents - administration & dosage (26) 26
care and treatment (26) 26
remission induction (25) 25
retrospective studies (25) 25
dna methylation (23) 23
expression (23) 23
research (23) 23
animals (22) 22
health aspects (22) 22
stem cells (22) 22
abridged index medicus (21) 21
antineoplastic agents - adverse effects (21) 21
diagnosis (21) 21
t cells (21) 21
follow-up studies (20) 20
hematology, oncology and palliative medicine (20) 20
mutation (20) 20
pathology (20) 20
polymerase chain reaction (20) 20
acute promyelocytic leukemia (19) 19
cell line, tumor (19) 19
lymphoma (18) 18
positron-emission tomography (18) 18
arsenicals - administration & dosage (17) 17
hematopoietic stem cells (17) 17
leukemia, promyelocytic, acute - drug therapy (17) 17
mice (17) 17
oxides - administration & dosage (17) 17
arsenic trioxide (16) 16
analysis (15) 15
apoptosis (15) 15
hemic and lymphatic diseases (15) 15
lymphoma, extranodal nk-t-cell - pathology (15) 15
lymphoma, t-cell - pathology (15) 15
administration, oral (14) 14
bone marrow (14) 14
neoplasm staging (14) 14
rituximab (14) 14
tumors (14) 14
acute myeloid-leukemia (13) 13
arsenicals - therapeutic use (13) 13
infection (13) 13
lymphoma, extranodal nk-t-cell - therapy (13) 13
oxides - therapeutic use (13) 13
t-cell (13) 13
cohort studies (12) 12
genetic aspects (12) 12
genetics & heredity (12) 12
malignancies (12) 12
methylation (12) 12
natural-killer-cell (12) 12
non-hodgkin's lymphomas (12) 12
prospective studies (12) 12
transplantation, homologous (12) 12
arsenic (11) 11
arsenicals - adverse effects (11) 11
bone marrow - pathology (11) 11
development and progression (11) 11
disease (11) 11
gene (11) 11
gene expression profiling (11) 11
genes (11) 11
human necessities (11) 11
hygiene (11) 11
killer cells, natural - pathology (11) 11
l-asparaginase (11) 11
medical or veterinary science (11) 11
non-hodgkins-lymphoma (11) 11
oxides - adverse effects (11) 11
preparations for medical, dental, or toilet purposes (11) 11
risk factors (11) 11
salvage therapy (11) 11
survival analysis (11) 11
time factors (11) 11
classification (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Best Practice & Research Clinical Haematology, ISSN 1521-6926, 09/2019, Volume 32, Issue 3, pp. 253 - 261
NK/T-cell lymphomas are extranodal EBV-related malignancies, mostly of NK-cell and occasionally of T-cell lineage. They are divided into nasal, non-nasal, and... 
NK/T-cell lymphoma | Nasal | Non-nasal | Immunotherapy | PET/CT | EBV | PD1 | Asparaginase
Journal Article
Blood, ISSN 0006-4971, 06/2013, Volume 121, Issue 25, pp. 4997 - 5005
Natural killer (NK)/T-cell lymphomas and NK-cell leukemias are aggressive malignancies. Occurring worldwide, they show a predilection for Asian and South... 
BARR-VIRUS-DNA | L-ASPARAGINASE | PROGNOSTIC-FACTORS | NASAL-TYPE | INVOLVED-FIELD RADIATION | NATURAL-KILLER-CELL | TUMOR-SUPPRESSOR GENE | T-CELL | COMPARATIVE GENOMIC HYBRIDIZATION | HEMATOLOGY | CLINICOPATHOLOGICAL FEATURES | Lymphoma, Extranodal NK-T-Cell - therapy | Lymphoma, Extranodal NK-T-Cell - pathology | Chemoradiotherapy | Humans
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 3990 - 3990
Abstract Introduction and objectives Intravenous arsenic trioxide (As2O3) has been tested in the frontline treatment of newly-diagnosed acute promyelocytic... 
Journal Article
Journal of Hematology and Oncology, ISSN 1756-8722, 04/2017, Volume 10, Issue 1, pp. 85 - 13
Extranodal natural killer (NK)/T-cell lymphoma is an aggressive malignancy of putative NK-cell origin, with a minority deriving from the T-cell lineage.... 
Nasal | NK/T-cell lymphoma | Prognostication | Non-nasal | Immunotherapy | L-asparaginase | Extranodal | PD1 | EBV DNA quantification | BARR-VIRUS DNA | INVOLVED-FIELD RADIATION | NATURAL-KILLER-CELL | TUMOR-SUPPRESSOR GENE | T-CELL | ONCOLOGY | NASAL-TYPE | LYMPHOPROLIFERATIVE DISEASE | HEMATOLOGY | STAGE IE | CONCURRENT CHEMORADIOTHERAPY | Lymphoma, Extranodal NK-T-Cell - genetics | Lymphoma, Extranodal NK-T-Cell - therapy | Prognosis | Lymphoma, Extranodal NK-T-Cell - pathology | Humans | Hematopoietic Stem Cell Transplantation | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Combined Modality Therapy - methods | Lymphoma, Extranodal NK-T-Cell - diagnosis | Radiotherapy | Asparaginase - therapeutic use | Salvage Therapy - methods | Killer cells | Lymphomas | Research | T cells | Transplants & implants | Leukemia | Liver | Cytotoxicity | Infections | Lymphocytes T | Transplantation | Malignancy | Computed tomography | Nose | Genetic analysis | Classification | Bone marrow | Remission | Natural killer cells | Localization | Polyclonal antibodies | Deoxyribonucleic acid--DNA | Immune system | Antigens | Autografts | Cell lineage | Salivary gland | Gastrointestinal tract | T cell receptors | Radiation therapy | Ribonucleic acid--RNA | Lymphoma | Chemotherapy | Anthracycline | Medical prognosis | Stem cells | Positron emission tomography | Skin tests | Asparaginase | Apoptosis | Tumors
Journal Article
Experimental and Molecular Medicine, ISSN 1226-3613, 01/2015, Volume 47, pp. 1 - 7
Epstein Barr virus (EBV)-associated lymphoproliferative diseases (LPDs) express all EBV latent antigens (type III latency) in immunodeficient patients and... 
생화학
Journal Article
Blood, ISSN 0006-4971, 09/2015, Volume 126, Issue 12, pp. 1400 - 1401
In this issue of Blood, Yang et al have proposed that for early-stage nasal type natural killer (NK)/T-cell lymphoma, combined radiotherapy (RT), and... 
L-ASPARAGINASE | MULTICENTER | THERAPY | BARR-VIRUS DNA | HEMATOLOGY | SMILE | Female | Male | Chemoradiotherapy - methods | Lymphoma, Extranodal NK-T-Cell - drug therapy | Lymphoma, Extranodal NK-T-Cell - radiotherapy | Humans
Journal Article
Blood, ISSN 0006-4971, 04/2017, Volume 129, Issue 17, pp. 2437 - 2442
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 2166 - 2166
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 4558 - 4558
Journal Article
Blood, ISSN 0006-4971, 11/2013, Volume 122, Issue 21, pp. 2678 - 2678
Abstract Approximately 20 percent of patients with acute promyelocytic leukemia (APL) relapse after initial remission. More than 80 percent of these patients... 
Journal Article
Journal of Clinical and Experimental Hematopathology, ISSN 1346-4280, 2011, Volume 51, Issue 1, pp. 21 - 28
Natural killer (NK) cell lymphomas are rare malignancies. They are classified as extranodal NK/T-cell lymphoma, nasal type, and aggressive NK cell leukemia. NK... 
natural killer cell leukemia | radiotherapy | hematopoietic stem cell transplantation | chemotherapy | natural killer cell lymphoma
Journal Article
Expert review of hematology, 09/2019, p. 1
: Natural killer (NK)/T-cell lymphomas are aggressive malignancies that present predominantly in nasal and adjacent sites (nasal subtype), occasionally in... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.